VIATRIS INC. Public Float
VIATRIS INC. (VTRS) had Public Float of $10.38 billion as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $10.38B.
- 2024-06-30: Entity Public Float $12.66B.
- 2023-06-30: Entity Public Float $11.94B.
- 2022-06-30: Entity Public Float $12.66B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $10.38B 10-K · filed 2026-02-26 |
| 2024-06-30 | $12.66B 10-K/A · filed 2025-04-30 |
| 2023-06-30 | $11.94B 10-K/A · filed 2024-04-26 |
| 2022-06-30 | $12.66B 10-K/A · filed 2023-04-28 |
| 2021-06-30 | $17.24B 10-K/A · filed 2022-04-29 |
| 2020-06-26 | $0.00 10-K/A · filed 2021-04-30 |
| 2019-12-31 | $0.00 10-K · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |